Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

6.80EUR
4:35pm GMT
Change (% chg)

€0.10 (+1.57%)
Prev Close
€6.70
Open
€6.70
Day's High
€6.99
Day's Low
€6.70
Volume
23,533
Avg. Vol
51,113
52-wk High
€19.31
52-wk Low
€5.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.27 -1.060
FY 2017 Dec '17 1.58 -1.516
Jun '17 1.79 -1.420
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 7.57 13.00 2.00 9.90
Earnings (per share)
Year Ending Dec-19 3 -3.07 -2.35 -3.54 -2.52
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta 0.86 1.08 0.90
Price to Sales (TTM) 80.61 49.51 6.28
Price to Book (MRQ) -- 10.16 5.27
Price to Tangible Book (MRQ) -- 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions -- 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -25.59 130.04 9.72
Sales (TTM) vs TTM 1 Yr. Ago -8.67 47.85 5.87
Sales - 5 Yr. Growth Rate 35.25 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.52 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -27.13 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate 81.34 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) -- 3.43 3.08
LT Debt to Equity (MRQ) -- 18.73 11.38
Total Debt to Equity (MRQ) -- 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -732.50 -- --
EBITD - 5 Yr. Avg -321.23 -110.00 12.88
Operating Margin (TTM) -736.87 -184.42 6.20
Operating Margin - 5 Yr. Avg. -331.17 -126.43 8.32
Pre-Tax Margin (TTM) -727.19 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -337.58 -132.58 8.62
Net Profit Margin (TTM) -727.87 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -337.31 -136.98 4.89
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,447 7,650,742 844,239,900
Net Income/Employee (TTM) -301,682 652,581 100,064,185
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) -- 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.45 11.08
Return on Assets - 5 Yr. Avg. -38.25 5.52 12.21
Return on Investment (TTM) -- 8.99 14.48
Return on Investment - 5 Yr. Avg. -46.07 6.85 15.88
Return on Equity (TTM) -- 10.13 15.99
Return on Equity - 5 Yr. Avg. -51.29 8.39 17.00
  1 Year 3 Year 5 Year
Sales % 41.28 31.92 35.25
EPS (TTM) % -27.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.30 -12.52 36 99
13 Week -7.07 -10.79 72 95
26 Week -12.20 -15.88 75 98
52 Week 35.52 13.27 99 72
YTD 76.06 59.71 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 49.56%
# of Holders: 20
Total Shares Held: 8,890,049
3 Mo. Net Change: -798,491
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 3
# Reduced Positions: 3
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.